The ECTRIMS Podcast Podcast Advertising - Audience, Sponsors & Contact

Overview

The ECTRIMS Podcast serves as a vital platform for the global Multiple Sclerosis (MS) community, offering in-depth discussions on groundbreaking research, innovative treatments, and comprehensive patient care. Hosted by experts, it features interviews with leading MS specialists, nurses, and researchers, exploring topics from the evolving role of healthcare professionals and the integration of AI in patient support to the critical importance of mental health in MS management. The podcast aims to educate and connect clinicians, researchers, and advocates, fostering a collaborative environment to advance MS understanding and improve the lives of those affected. It's essential listening for anyone seeking to stay informed on the latest developments and holistic approaches in MS care.

Show Impressions

Estimates only, not verified by show

Est. Podcast Downloads

60

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Direct Response

Brands with CTAs

BAD

0%

Host Read %

% of host read ads

GOOD

82%

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

The Bottom Line

This show has an estimated 60 audience size, runs 82% host read ads and promotes 0% of ads for direct response advertisers.

Recent Campaigns

	Advertisers	Week6/15	Week6/29
Alexion AstraZeneca Rare Diseasealexion.com	Alexion AstraZeneca Rare Disease	1		Test in progress 8%
MS Translatemstranslate.com.au	MS Translate	1		Test in progress 8%
Novartis, Roche and Alexion Pharmaceuticalsectrims.eu	Novartis, Roche and Alexion Pharmaceuticals		1	Test in progress 8%

Northwind Foodsnorthwindfoods.com	Northwind Foods		2	3	4		1	2	3		5	1	2		4	5	1		3	4	5		2	3	4	Core Performer 75%
Blue Canoe Financebluecanoe.io	Blue Canoe Finance	4	5	1		3	4	5		2	3	4		1	2	3		5	1	2		4	5	1		Core Performer 75%
SignalPath Labssignalpathlabs.com	SignalPath Labs	2	3		5	1	2		4	5	1		3	4	5		2	3	4		1	2	3		5	Core Performer 75%
Oak & Anchoroakandanchor.co	Oak & Anchor	5		2	3	4		1	2	3		5	1	2		4	5	1		3	4	5		2	3	Core Performer 75%
Brightline Healthbrightlinehealth.com	Brightline Health		4	5	1		3	4	5		2	3	4		1	2	3		5	1	2		4	5	1	Core Performer 75%

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Demographics

Location

Fans by country:

United States 88%

Canada 4%

United Kingdom 3%

Germany 3%

Australia 2%

Age Distribution

18-24

12.0%

25-34

28.0%

35-44

26.0%

45-54

18.0%

55-64

11.0%

65-99

5.0%

Income Brackets

$10k-20k

4.0%

$20k-30k

7.0%

$30k-40k

9.0%

$40k-50k

11.0%

$50k-60k

13.0%

$60k-70k

12.0%

$70k-80k

11.0%

$80k-90k

10.0%

$90k-100k

9.0%

$100k-150k

8.0%

$150k-200k

4.0%

$200k-1000k

2.0%

Gender

Male · 58.0%

Male58.0%
Female37.0%
Other5.0%

Education

Bachelor's

42.0%

Graduate

28.0%

High School

18.0%

Post Graduate

12.0%

Occupation

Professional

32.0%

Student

18.0%

Management

14.0%

Other

13.0%

Sales

12.0%

Technical

11.0%

Family Status

Single · 42.0%

Single42.0%
Married35.0%
Parents23.0%

Ethnicity

White

68.0%

Hispanic

14.0%

Black

11.0%

Asian

7.0%

Engagement Style

Active listener

46.0%

Background listener

32.0%

Binge listener

22.0%

Language

English

94.0%

Spanish

4.0%

French

2.0%

Religion

Christianity · 52.0%

Christianity52.0%
Non-Religious48.0%

Brand Safety

Overall content risk rate

Low risk

35.0%

Risk breakdown

Share of content flagged by category

Explicit Language28.0%
Political Content5.0%
Violence2.0%

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Top Advertisers

Top Spenders	Est. Spent	Change	Host Read %	DR %	# of ads	Frequency	Top Shows
UCB	$5	0.0%	86%	0%	14.0ad units	Core Performer	+1
Novartis pharmaceuticals	$2	0.0%	100%	0%	5.0ad units	Core Performer	+1
Alexion AstraZeneca Rare Disease	$1	-100.0%	100%	0%	4.0ad units	Core Performer	+1

Northwind Foods ConsumerRetail	$120,000	+4.0%	62%	38%	3.20/mo	2.1ad units	Test run	S S
Blue Canoe Finance ConsumerRetail	$129,000	+5.0%	63%	37%	3.20/mo	2.1ad units	Core Performer	S S
SignalPath Labs ConsumerRetail	$138,000	+6.0%	64%	36%	3.20/mo	2.1ad units	Core Performer	S S
Oak & Anchor ConsumerRetail	$147,000	+7.0%	65%	35%	3.20/mo	2.1ad units	Core Performer	S S
Brightline Health ConsumerRetail	$156,000	+8.0%	66%	34%	3.20/mo	2.1ad units	Test run	S S

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Ads and Episodes

Fenebrutinib in Relapsing MS: FENhance Trial Results Explained

0:00 / 0:10

Brand Awareness

F

#1

Run on 1x episode

‌
‌
‌
‌

Unlock show and brand data, including top ads, overall spend, and the ability to listen to ads.

Recent Episodes

‌
‌
‌